Article ID Journal Published Year Pages File Type
8789945 Urologic Oncology: Seminars and Original Investigations 2018 11 Pages PDF
Abstract
Based on these results, bTURB is as safe and effective as mTURB in treatment of primary NMIBC. bTURB seems to have no evident advantages over mTURB with respect to operation time, perioperative and postoperative complication rates, and recurrence rates at 12 months.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , ,